Scale-up of integrated HIV services had reached the following number of sites:

• 752 static and 225 outreach HIV testing sites

• 744 (static) ART sites; 617 of these started at least one pregnant or breastfeeding

  woman and 709 started asymptomatic patients (Test & Treat) this quarter

• 681 sites with HIV-exposed children in follow-up

1,133,277 persons were tested for HIV and received their results; 271,901 (24%) accessed HIV testing for the first time; 861,326 (74%) were repeat testers and 39,432 (5%) of these received confirmatory testing (after having tested positive in the past). 34,414 (3.1%) clients received a positive result for the first time.

21,111 (97%) of 21,874 blood units collected were screened for (at least) HIV, hepatitis B and syphilis.

157,822 (98%) of 163,363 women at ANC had their HIV status ascertained; 11,435 (8%) of these were HIV positive. 144,426 (99%) of 145,489 women at maternity had their HIV status ascertained 10,253 (7%) of these were HIV positive.

31,371 patients started ART this quarter; 64% were classified as asymptomatic / in WHO stage 1 and started under the new “Test & Treat” policy.

782,144 patients were alive and on ART by end of June 2018. This means that 73% of the estimated 1,058,000 HIV positive population was on ART. ART coverage was 68% (46,140 / 68,000) for children and 74% (736,004 / 990,000) for adults.

67,710 (88%) of 76,911 viral load results from routine monitoring were <1000 copies/ml. Viral suppression rates for routine samples among children (0-14 years) and adults (15+ years) were 55% and 89%, respectively.

74% of adults and 78% of children were retained alive on ART at 12 months after initiation.

675,538 (93%) of 730,071 patients on first line adult ART were on TDF/3TC/EFV.

12,474 4 (89%) of an estimated 14,000 HIV infected pregnant women in Malawi were on ART this quarter. 8,668 (69%) of these were already on ART when getting pregnant and 3,806 (31%) started ART during pregnancy/delivery.

An additional 1,313 breastfeeding women started ART in WHO stage 1 or 2.

77%, 74%, 69% and 64% of women started while pregnant or breastfeeding were retained on ART at 6, 12, 24 and 36 months after initiation, respectively.

9,550 (7%) of infants discharged alive from maternity were known to be HIV exposed, 9,039 (95%) of these received ARV prophylaxis (nevirapine). 11,405 were enrolled in exposed child follow-up before age 2 months.

A total of 14,508 HIV exposed children were newly enrolled for follow-up this quarter.